193 related articles for article (PubMed ID: 30044991)
1. Epithelial-Mesenchymal Transition Induces Podocalyxin to Promote Extravasation via Ezrin Signaling.
Fröse J; Chen MB; Hebron KE; Reinhardt F; Hajal C; Zijlstra A; Kamm RD; Weinberg RA
Cell Rep; 2018 Jul; 24(4):962-972. PubMed ID: 30044991
[TBL] [Abstract][Full Text] [Related]
2. Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.
Kusumoto H; Shintani Y; Kanzaki R; Kawamura T; Funaki S; Minami M; Nagatomo I; Morii E; Okumura M
Cancer Sci; 2017 Mar; 108(3):528-535. PubMed ID: 28004467
[TBL] [Abstract][Full Text] [Related]
3. Ezrin is required for epithelial-mesenchymal transition induced by TGF-β1 in A549 cells.
Chen MJ; Gao XJ; Xu LN; Liu TF; Liu XH; Liu LX
Int J Oncol; 2014 Oct; 45(4):1515-22. PubMed ID: 25051016
[TBL] [Abstract][Full Text] [Related]
4. In vitro anti-motile effects of Rhoifolin, a flavonoid extracted from Callicarpa nudiflora on breast cancer cells via downregulating Podocalyxin-Ezrin interaction during Epithelial Mesenchymal Transition.
Xiong L; Lu H; Hu Y; Wang W; Liu R; Wan X; Fu J
Phytomedicine; 2021 Dec; 93():153486. PubMed ID: 34649211
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation.
Wang A; Lu C; Ning Z; Gao W; Xie Y; Zhang N; Liang J; Abbasi FS; Yan Q; Liu J
Oncotarget; 2017 Apr; 8(17):28247-28259. PubMed ID: 28423676
[TBL] [Abstract][Full Text] [Related]
6. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
Liu P; Yang P; Zhang Z; Liu M; Hu S
Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
[TBL] [Abstract][Full Text] [Related]
7. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
8. Interaction Between Ezrin and Cortactin in Promoting Epithelial to Mesenchymal Transition in Breast Cancer Cells.
He J; Ma G; Qian J; Zhu Y; Liang M; Yao N; Ding Q; Chen L; Liu X; Xia T; Wang S
Med Sci Monit; 2017 Apr; 23():1583-1596. PubMed ID: 28364518
[TBL] [Abstract][Full Text] [Related]
9. PODXL, negatively regulated by KLF4, promotes the EMT and metastasis and serves as a novel prognostic indicator of gastric cancer.
Zhang J; Zhu Z; Wu H; Yu Z; Rong Z; Luo Z; Xu Y; Huang K; Qiu Z; Huang C
Gastric Cancer; 2019 Jan; 22(1):48-59. PubMed ID: 29748877
[TBL] [Abstract][Full Text] [Related]
10. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.
Sizemore S; Cicek M; Sizemore N; Ng KP; Casey G
Cancer Res; 2007 Jul; 67(13):6183-91. PubMed ID: 17616675
[TBL] [Abstract][Full Text] [Related]
11. A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells.
Wong BS; Shea DJ; Mistriotis P; Tuntithavornwat S; Law RA; Bieber JM; Zheng L; Konstantopoulos K
Cancer Res; 2019 Jun; 79(11):2878-2891. PubMed ID: 30975647
[TBL] [Abstract][Full Text] [Related]
12. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.
Chen D; Dang BL; Huang JZ; Chen M; Wu D; Xu ML; Li R; Yan GR
Oncotarget; 2015 Oct; 6(32):32701-12. PubMed ID: 26196741
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy.
Snyder KA; Hughes MR; Hedberg B; Brandon J; Hernaez DC; Bergqvist P; Cruz F; Po K; Graves ML; Turvey ME; Nielsen JS; Wilkins JA; McColl SR; Babcook JS; Roskelley CD; McNagny KM
Breast Cancer Res; 2015 Mar; 17(1):46. PubMed ID: 25887862
[TBL] [Abstract][Full Text] [Related]
14. Podocalyxin-Like Protein 1 Regulates TAZ Signaling and Stemness Properties in Colon Cancer.
Lee WY; Kuo CC; Lin BX; Cheng CH; Chen KC; Lin CW
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946619
[TBL] [Abstract][Full Text] [Related]
15. Ezrin/NF-kB activation regulates epithelial- mesenchymal transition induced by EGF and promotes metastasis of colorectal cancer.
Li Y; Lin Z; Chen B; Chen S; Jiang Z; Zhou T; Hou Z; Wang Y
Biomed Pharmacother; 2017 Aug; 92():140-148. PubMed ID: 28535417
[TBL] [Abstract][Full Text] [Related]
16. Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer.
Kim RK; Kaushik N; Suh Y; Yoo KC; Cui YH; Kim MJ; Lee HJ; Kim IG; Lee SJ
Oncotarget; 2016 Aug; 7(33):53430-53442. PubMed ID: 27462787
[TBL] [Abstract][Full Text] [Related]
17. EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation.
Kiefel H; Bondong S; Pfeifer M; Schirmer U; Erbe-Hoffmann N; Schäfer H; Sebens S; Altevogt P
Carcinogenesis; 2012 Oct; 33(10):1919-29. PubMed ID: 22764136
[TBL] [Abstract][Full Text] [Related]
18. Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.
Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Hanazaki K; Saibara T
Cancer Sci; 2016 Oct; 107(10):1430-1442. PubMed ID: 27461278
[TBL] [Abstract][Full Text] [Related]
19. Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition.
Meng X; Ezzati P; Wilkins JA
PLoS One; 2011 Apr; 6(4):e18715. PubMed ID: 21533279
[TBL] [Abstract][Full Text] [Related]
20. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]